HIGHLIGHTS
- who: Silvia Parolo from the Fondazione the Microsoft Research-University of have published the Article: Single-cell-led drug repurposing for Alzheimeru2019s disease, in the Journal: Scientific Reports Scientific Reports
- what: To obtain genetic and gene_expression evidence, the authors focused on the results of AD GWAS and single nucleus RNA-seq (snRNA-seq) of AD brains and controls. These sources were complemented with literature data that may capture the results of targeted approaches focused on candidate disease pathways. In the study , they were identified as AD repurposing candidates thanks to the proximity of FGFR1 and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.